Editorial Policy

1. Editorial Mission

goglp1.com provides independent, evidence-based information about GLP-1 receptor agonist medications to help patients and consumers make informed decisions. Our goal is to be the most comprehensive and trustworthy resource for GLP-1 therapy information, pricing, and provider comparison.

We cover semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and emerging GLP-1/GIP dual agonists, as well as compounded formulations available through licensed telehealth providers.

2. Editorial Team

All content is produced by the GoGLP1 Editorial Team, a collective of health content professionals with expertise in clinical pharmacology, metabolic medicine, patient education, and telehealth platform evaluation.

All content is reviewed by the editorial team for clinical accuracy. Clinical claims are verified against current FDA prescribing information and peer-reviewed literature before publication. We do not fabricate reviewer profiles — our sourcing methodology is fully transparent and traceable.

We attribute written content to the editorial team as a whole rather than to individual named authors. This reflects our collaborative production process, where every article is the product of multiple contributors.

3. Medical Review Board

The GoGLP1 Medical Review Board is the organizational body responsible for verifying the clinical accuracy of all health content published on goglp1.com. It operates as part of our editorial process, not as a separate clinical practice.

Every medication page, clinical claim, and safety recommendation is verified against FDA prescribing information and peer-reviewed literature under the board's review process before publication. The board does not provide medical advice — it ensures our educational content is accurate, current, and responsibly presented.

The Medical Review Board is an organizational attribution. We do not fabricate individual reviewer profiles. All sourcing is transparent and traceable to primary clinical literature.

4. Sourcing Standards

Every clinical claim on goglp1.com meets one or more of the following source criteria:

• Peer-reviewed literature: Published research from indexed medical journals (PubMed, MEDLINE).
• FDA documentation: Official drug labels, approval letters, safety communications, and shortage reports.
• Clinical guidelines: Recommendations from the American Diabetes Association (ADA), American Association of Clinical Endocrinology (AACE), and comparable bodies.
• Prescribing information: Official package inserts and manufacturer dosing guidance.
• Regulatory filings: State pharmacy board records, DEA registrations, and compounding facility inspections where applicable.

We do not cite press releases, marketing materials, or unsubstantiated claims as primary sources for clinical information. When we reference news coverage, we independently verify the underlying facts.

5. Review Process

Every article goes through the following stages before publication:

1. Research: The editorial team identifies and reviews relevant primary sources for the topic.
2. Drafting: Content is written following our style guide, with inline source citations.
3. Fact-checking: Data points, pricing, dosing, and regulatory details are verified against primary sources.
4. Medical review: All clinical content is reviewed by the editorial team for accuracy, safety, and alignment with FDA prescribing information. Claims are verified against peer-reviewed literature.
5. Editorial review: A separate editor reviews for clarity, balance, and completeness.
6. Publication: The article is published with the review date noted.

Published content is re-reviewed on a regular schedule. Articles about active medications are reviewed at minimum every 90 days. Articles affected by breaking regulatory or safety news are updated within 48 hours.

6. Pricing Data

Medication pricing on goglp1.com is collected from the following sources:

• GoodRx and comparable pharmacy discount platforms
• Manufacturer websites and patient assistance program pages
• Telehealth provider websites (published list prices)
• Medicare/Medicaid formulary data where available

Prices are verified on a regular schedule and are clearly labeled with the date of last verification. All prices are subject to change and may vary by location, pharmacy, and insurance status. We clearly disclose when a price is an estimate versus a verified figure.

7. Provider Reviews

Telehealth provider reviews and rankings are based on a standardized evaluation methodology that includes:

• Published pricing and subscription structure
• Prescribing practices (branded vs. compounded, 503A vs. 503B pharmacies)
• Customer support availability and responsiveness
• Platform usability and patient experience
• Pharmacy licensing and verification
• Refill and continuity of care policies

Provider reviews are updated at minimum every 90 days or when material changes in pricing, services, or regulatory status are identified.

8. Corrections Policy

We take factual accuracy seriously. Our corrections process:

• Factual errors: Corrected within 24 hours of confirmation. A correction notice is appended to the article.
• Outdated information: Updated during the next scheduled review cycle, or sooner if the information could affect clinical decisions.
• Clarifications: Added when reader feedback indicates that content is ambiguous or misleading, even if technically accurate.

To report an error or concern, please use our contact page. All reports are reviewed by the editorial team.

9. Commercial Independence

goglp1.com earns revenue through affiliate partnerships with some of the telehealth providers we review. Our editorial process is independent of these commercial relationships:

• Provider rankings are based on our standardized evaluation criteria, not affiliate status.
• Affiliate partnerships do not influence which providers we review or the ratings we assign.
• All affiliate relationships are clearly disclosed on our disclosures page and on individual review pages.
• We review and rank providers with whom we have no commercial relationship.

For full details, see our affiliate disclosures.